Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-24 @ 10:53 PM
NCT ID:
NCT02173769
Eligibility Criteria:
Inclusion criteria:
* Female and male patients \>= 40 years
* COPD GOLD 2014 B - D
* Treatment with Spiriva® Respimat® plus Striverdi® Respimat® or Spiriva® 18 Microgramm plus Striverdi® Respimat® acc. to the Summary of Product Characteristics (SmPC), no change of routine diagnostics and treatment
* Signed informed consent form before inclusion into the non-interventional study (NIS)
Exclusion criteria:
* Patients with contraindications acc. to the Summary of Product Characteristics (SmPC)
* pregnant and breastfeeding women
* patients who are taking part in a different non-interventional study (NIS) or an interventional clinical study at the same time are not to be enrolled
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT02173769
Study Brief:
Protocol Section:
NCT02173769